Detailed answers about BATH INSTITUTE FOR RHEUMATIC DISEASES, including incorporation, status, business activity, and accounts information.
When was BATH INSTITUTE FOR RHEUMATIC DISEASES founded?
BATH INSTITUTE FOR RHEUMATIC DISEASES was officially incorporated on 16 March 1994 and is registered under company number 02908933. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is BATH INSTITUTE FOR RHEUMATIC DISEASES?
PRI/LBG/NSC (Private, Limited by guarantee, no share capital, use of 'Limited' exemption). This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations.
What is the current status of BATH INSTITUTE FOR RHEUMATIC DISEASES?
BATH INSTITUTE FOR RHEUMATIC DISEASES's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does BATH INSTITUTE FOR RHEUMATIC DISEASES do?
BATH INSTITUTE FOR RHEUMATIC DISEASES operates in the following sectors: 72190 - Other research and experimental development on natural sciences and engineering, 74990 - Non-trading company. These SIC codes provide insight into the company's business activities and industry focus.
What is BATH INSTITUTE FOR RHEUMATIC DISEASES's registered address?
The registered office address of BATH INSTITUTE FOR RHEUMATIC DISEASES is D1 WOLFSON BUILDING ROYAL UNITED HOSPITALS BATH NHS FOUNDATION TRUST, COMBE PARK, BATH, ENGLAND, BA1 3NG. This is the official address filed with Companies House for legal and statutory correspondence.
Is BATH INSTITUTE FOR RHEUMATIC DISEASES financially stable?
The most recent accounts for BATH INSTITUTE FOR RHEUMATIC DISEASES were made up to 31 March 2025, filed as TOTAL EXEMPTION FULL. Next accounts are due by 31 December 2026.